BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29594801)

  • 21. Preoperative hepatic dysfunction could predict postoperative mortality and morbidity in patients undergoing cardiac surgery: Utilization of the MELD scoring system.
    Murata M; Kato TS; Kuwaki K; Yamamoto T; Dohi S; Amano A
    Int J Cardiol; 2016 Jan; 203():682-9. PubMed ID: 26583843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Easy prognostic assessment of concomitant organ failure in critically ill patients undergoing mechanical ventilation.
    Wernly B; Frutos-Vivar F; Peñuelas O; Raymondos K; Muriel A; Du B; Thille AW; Ríos F; González M; Del-Sorbo L; Del Carmen Marín M; Pinheiro BV; Soares MA; Nin N; Maggiore SM; Bersten A; Kelm M; Amin P; Cakar N; Lichtenauer M; Suh GY; Abroug F; Jibaja M; Matamis D; Zeggwagh AA; Sutherasan Y; Anzueto A; Esteban A; Jung C
    Eur J Intern Med; 2019 Dec; 70():18-23. PubMed ID: 31606309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation.
    Lv J; Ye Y; Li Z; Zhang B; Liu Q; Zhao Q; Zhao Z; Wang W; Zhang H; Duan Z; Wang B; Yu Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
    Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):227-239. PubMed ID: 35612991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thinking fast and slow: lactate and MELD-XI (model for end-stage liver disease excluding INR) are useful for estimating mortality after cardiopulmonary resuscitation.
    Rezar R; Lichtenauer M; Schwaiger P; Seelmaier C; Pretsch I; Ausserwinkler M; Reichle J; Jirak P; Jung C; Strohmer B; Hoppe UC; Wernly B
    Minerva Anestesiol; 2021 Sep; 87(9):1017-1024. PubMed ID: 33938680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Ichikawa T; Yamashita M; Uchida S; Maekawa E; Terada T; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    J Cardiol; 2023 Feb; 81(2):215-221. PubMed ID: 36167755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
    Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End-Stage Liver Disease Models and Outcomes in Pediatric Patients Supported With Short-Term Continuous-Flow Ventricular Assist Devices.
    Malik G; Pidborochynski T; Buchholz H; Freed DH; Al-Aklabi M; Bozso SJ; Choudhry S; Anand V; Holinski P; Conway J
    ASAIO J; 2020 Aug; 66(8):933-938. PubMed ID: 32740355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units.
    İdin K; Dereli S; Kaya A; Yenerçağ M; Yılmaz AS; Tayfur K; Gülcü O
    Scand Cardiovasc J; 2021 Aug; 55(4):237-244. PubMed ID: 33491501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Different Versions of the Model for End-Stage Liver Disease Score in Patients Undergoing Percutaneous Coronary Intervention.
    He HM; He C; You ZB; Zhang SC; Lin XQ; Luo MQ; Lin MQ; Zhang LW; Lin KY; Guo YS
    Angiology; 2023 Feb; 74(2):159-170. PubMed ID: 35511114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MELD-XI is predictive of mortality in venoarterial extracorporeal membrane oxygenation.
    Ayers B; Wood K; Melvin A; Prasad S; Gosev I
    J Card Surg; 2020 Jun; 35(6):1275-1282. PubMed ID: 32340073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive Value of Models for End-Stage Liver Disease Score in Patients With Pulsatile Flow POLVAD MEV Left Ventricular Assist Device Support.
    Nadziakiewicz P; Szyguła-Jurkiewicz B; Pacholewicz J; Zakliczyński M; Przybyłowski P; Krauchuk A; Łowicka M; Zembala M
    Transplant Proc; 2018 Sep; 50(7):2075-2079. PubMed ID: 30177112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass.
    Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
    J Vasc Surg; 2016 Jul; 64(1):124-30. PubMed ID: 26994957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.
    Egbe AC; Miranda WR; Dearani J; Kamath PS; Connolly HM
    J Am Coll Cardiol; 2020 Dec; 76(25):2968-2976. PubMed ID: 33334426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMMELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection Fraction.
    Wang S; Wang Y; Luo M; Lin K; Xie X; Lin N; Yang Q; Zou T; Chen X; Xie X; Guo Y
    Front Cardiovasc Med; 2021; 8():650191. PubMed ID: 34113661
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic impact of hepatorenal function in patients undergoing transcatheter tricuspid valve repair.
    Tanaka T; Kavsur R; Sugiura A; Vogelhuber J; Öztürk C; Weber M; Tiyerili V; Zimmer S; Nickenig G; Becher MU
    Sci Rep; 2021 Jul; 11(1):14420. PubMed ID: 34257395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
    Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.